Patient

P2B-029

completed Phase II

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Sarcoma Oncology Center (Santa Monica, CA) (Dr. Reyes)

consented 2012-08-15

Sarcoma Oncology Center (Santa Monica, CA)

Adverse events

Serious AEs

Open data queries

Luna dropout signal

—

not on Luna

Adverse events 3

mild assessed 2012-09-04

Grade 1 asthenia with onset in cycle 1 (2012-09-04); assessed as not related to study drug (not related); resolved 2012-09-21.

moderate assessed 2012-08-26

Grade 2 febrile neutropenia with onset in cycle 1 (2012-08-26); assessed as related to study drug (probable); resolved 2012-09-11; action: drug withdrawn.

mild assessed 2012-08-23

Grade 1 nausea with onset in cycle 1 (2012-08-23); assessed as not related to study drug (not related); resolved 2012-08-27.

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users